Literature DB >> 12558365

Adopting more systematic approaches to hepatitis C treatment in correctional facilities.

Theodore M Hammett.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12558365     DOI： 10.7326/0003-4819-138-3-200302040-00021

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

2.  Principles to Guide National Data Collection on the Health of Persons in the Criminal Justice System.

Authors:  Ingrid A Binswanger; Laura M Maruschak; Shane R Mueller; Marc F Stern; Stuart A Kinner
Journal:  Public Health Rep       Date:  2019 May/Jun       Impact factor: 2.792

3.  A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.

Authors:  John T Nguyen; Josiah D Rich; Bradley W Brockmann; Fred Vohr; Anne Spaulding; Brian T Montague
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

4.  A missed opportunity: hepatitis C screening of prisoners.

Authors:  Grace E Macalino; Darpun Dhawan; Josiah D Rich
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

5.  Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.

Authors:  Duncan Smith-Rohrberg Maru; Robert Douglas Bruce; Sanjay Basu; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

6.  Hepatitis C Testing and Linkage to Care Among Adults on Probation in a Large US City.

Authors:  Kevin F Kamis; David L Wyles; Matthew S Minturn; Tracy Scott; Dean McEwen; Hermione Hurley; Scott J Prendergast; Sarah E Rowan
Journal:  Open Forum Infect Dis       Date:  2021-12-16       Impact factor: 3.835
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.